I hope everyone had a pleasant Labor Day, and has had a wonderful summer. I'll be finishing the summer's blogs with some more good news about the treatment of Alzheimer's disease. Animal studies continue to be highly informative about approaches that can be taken in the treatment of Alzheimer's disease. A group of researchers... Read more
In my most recent blog, I reviewed the concepts of phase 1, phase 2 and phase 3 research trials and briefly summarized the results from a recent phase three study of a drug called tramiprosate. Today, I'd like to focus on an exciting, new, and potentially important phase 1 study. As I indicated, phase 1 is the earliest and most basic... Read more
What's new on the research front for the treatment of Alzheimer's disease? And, what do the terms phase 2 and phase 3 research mean? In the last two decades, studies on the impact and effects of certain drugs have become increasingly common. In the 1990s, an explosive increase occurred in the area of neuro-pharmaceutical research, which is... Read more
What's new on the research front for the treatment of Alzheimer's disease? And, what do the terms phase 2 and phase 3 research mean? In the last two decades, drug studies have become increasingly common. The 1990s was the "Decade of the Brain," and an explosive increase has occurred in the area of neuro-pharmaceutical... Read more
One of the most common distinctions that physicians make in seeing patients with complaints of memory trouble is the distinction between dementia and depression. Before I continue, I would once again like to distinguish between the terms dementia and Alzheimer's disease. Dementia is a brain problem that includes impairment of memory... Read more